Stay updated on Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial
Sign up to get notified when there's something new on the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page.

Latest updates to the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page
- CheckyesterdayChange DetectedThe footer's ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0, while the page still shows a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” was added, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check29 days agoChange DetectedThe site revision displayed in the footer changes from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the usual content, replacing the study details with an error screen. This change represents an access restriction that prevents users from viewing the core information on the page.SummaryDifference20%

- Check50 days agoChange DetectedThe page's revision metadata was updated from v3.6.6 to v3.7.0, indicating a newer version of the study record.SummaryDifference0.2%

- Check64 days agoChange DetectedThe page shows a new revision number, updating from v3.6.5 to v3.6.6, indicating a newer build of the page software. This appears to be a backend/frontend release rather than a change to the study details.SummaryDifference0.2%

Stay in the know with updates to Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page.